Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center

Dalbavancin is a lipoglycopeptide approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The aim of the study was to evaluate the efficacy and safety in all patients who received at least one administration of dalbavancin. Methods: We carried out a retrospective s...

Full description

Bibliographic Details
Main Authors: Lucia Brescini, Filippo Della Martera, Gianluca Morroni, Sara Mazzanti, Maria Di Pietrantonio, Paolo Mantini, Bianca Candelaresi, Francesco Pallotta, Silvia Olivieri, Valentina Iencinella, Sefora Castelletti, Emanuele Cocci, Rosaria G. Polo, Salvatore Veccia, Oscar Cirioni, Marcello Tavio, Andrea Giacometti
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antibiotics
Subjects:
dalbavancin
ABSSSI
prosthetic joint infections
osteomyelitis
Online Access:https://www.mdpi.com/2079-6382/10/9/1129

Internet

https://www.mdpi.com/2079-6382/10/9/1129

Similar Items